La ciencia psicodélica del siglo XXI

Summary

The study discusses the need for regulatory changes in Argentina to facilitate research on serotonergic psychedelics in Psychiatry. It reviews the historical and ethnopharmacological context of classic psychedelics from the 1950s to present, highlighting cultural and political controversies. The paper argues for a stigma-free approach to recognize the therapeutic potential of these substances, aiming to address severe mental illnesses that remain inadequately treated.

Study at a glance

Abstract

We are currently witnessing a renaissance of psychedelic science in clinical research. In Argentina, the challenges related to its study and the development of new treatments in the field of Psychiatry are subject to the adoption of certain regulatory policies. The evolution of the knowledge about the effects, mechanisms of action and therapeutic potential of serotonergic psychedelics warrants a change in the regulatory framework for their use in clinical research. In a world that demands rapid flexibility and adaptation, we should avoid waiting for advances from developed countries. It is evident that psychopharmacological progress in the last thirty years have not been up to the expectations of the so-called "decade of the brain". Aware of these limitations, in this paper we carry out a historical and ethnopharmacological review of the classic psychedelics, from the 50's to the present -without ignoring their ancestral uses-, in order to highlight the political and cultural controversies that these molecules have raised in the field of Psychiatry. We hope to promote in the local environment an approach devoid of stigmas and that considers the therapeutic potential of these substances, with the ultimate goal of providing relief to severe mental illnesses that to this day continue to remain unanswered.

Tags